Parabilis Medicines, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Parabilis Medicines, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-9.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 55% of Healthcare companies in United States.
Cash Cushion Ratio
−1%Debt, after subtracting cash, equals 1% of its market value (net debt).
Lower than 69% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Parabilis Medicines, Inc. made a loss over the last year. Parabilis Medicines, Inc. owes $0.11 for every $1 it owns. Parabilis Medicines, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossParabilis Medicines, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.17The share price is 3.17 times Parabilis Medicines, Inc.'s book value per share, higher than 58% of Healthcare companies in United States.
Market cap
$3.3 BThe total market value of all of Parabilis Medicines, Inc.'s shares at today's price (share price × number of shares), larger than 81% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.0 BWhat Parabilis Medicines, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.48Net worth divided by the number of shares. The share price of $26.92 is 3.2 times this, which is the P/B above.
Owes vs Owns
0.11×Parabilis Medicines, Inc. owes $0.11 for every $1 it owns (low), lower than 85% of Healthcare companies in United States.
Dividend yield
NoneParabilis Medicines, Inc. does not currently pay a dividend.
Profit growth
LossParabilis Medicines, Inc. made a loss in each of the last two years.
Interest cover
Not coveredParabilis Medicines, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtParabilis Medicines, Inc. had $31 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Parabilis Medicines, Inc.: $3.3 B ÷ $1.0 B (30 Jun 2026) = 3.2.
How much does Parabilis Medicines, Inc. owe compared with what it owns?
Parabilis Medicines, Inc. owes $0.11 for every $1 it owns (low), lower than 85% of Healthcare companies in United States.
Does Parabilis Medicines, Inc. pay a dividend?
No. Parabilis Medicines, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.